![](https://endpts.com/wp-content/uploads/2016/10/stencil.twitter-post-123.png)
J&J makes new investments in microbiome R&D; UK’s Arix out to raise £100 million for new biotech investments
• J&J is making some new investments in microbiome research, including adding Caelus Health to its J&J Innovation portfolio. “These collaborations and investments will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.